Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Larry Ramer

Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too?

Pfizer (PFE) has reportedly decided to sell its entire remaining stake in BioNTech (BNTX), showing a lack of confidence in BioNTech’s Covid-19 vaccine and in BNTX stock. Meanwhile, BioNTech has generally been generating relatively steep losses and its shares are not cheap. 

Finally, while its two most prominent drug candidates show some potential, they both have significant weaknesses and consequently may very well not end up generating large amounts of revenue for the firm. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.